Ozempic

Ozempic, a brand name for the medication semaglutide, is a prescription injectable medicine primarily used in the management of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by increasing insulin release, decreasing the amount of sugar the liver produces, and suppressing appetite. While its primary use is to improve blood sugar control in adults with type 2 diabetes, Ozempic has also gained attention for its significant side effect of weight loss in patients. This has led to its off-label use and growing interest as a weight management solution for individuals looking to lose weight, even among those without diabetes. The relationship between Ozempic and health extends beyond glycemic control to include potential benefits in weight reduction and associated improvements in cardiovascular risk factors, making it a subject of interest in the broader context of obesity management and overall metabolic health.